Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Endometrioid × Hysterectomy × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 7 Uterine Cervical Neoplasms 6 Leiomyoma 6 Ovarian Neoplasms 4 Myofibroma 3 Uterine Neoplasms 2 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 2 Carcinoma, Ovarian Epithelial 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Prolapse 1 Uterine Cervical Dysplasia 1 Sarcoma 1 Precancerous Conditions 1 Metrorrhagia 1 Menstruation Disturbances 1 Menorrhagia 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Fallopian Tube Neoplasms 1 Endometriosis 1 Endometrial Hyperplasia 1 Disease 1 Carcinoma, Squamous Cell 1 Carcinoma, Endometrioid 1 Carcinoma, Adenosquamous 1 Adenomyosis 1 Adenocarcinoma 1

Interventions

Nivolumab 3 Specimen Handling 2 Paclitaxel 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 Carboplatin 2 CTLA-4 Antigen 2 temsirolimus 1 sintilimab 1 serabelisib 1 sapanisertib 1 rucaparib 1 pembrolizumab 1 palbociclib 1 olaparib 1 durvalumab 1 defactinib 1 ceralasertib 1 cabozantinib 1 adavosertib 1 Therapeutics 1 Taxes 1 Restraint, Physical 1 Radiation, Ionizing 1 Radiation 1 RO5126766 1 Platinum 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Hysterectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02598219 2026-03-18

SENTIRAD

Centre Oscar Lambret

Phase 3 Active not recruiting

Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡